Literature DB >> 7550872

High nitric oxide synthase activity in endothelial cells in ulcerative colitis.

E Iwashita1, T Miyahara, K Hino, T Tokunaga, H Wakisaka, Y Sawazaki.   

Abstract

Endothelial nitric oxide (NO) synthase, a unique NO synthase (NOS) isoform that is expressed constitutively by the vascular endothelium both in vivo and in vitro, is believed to be essential to systemic and/or local vascular integrity. NOS expression by endothelial cells may indicate vascular activation. We successfully established a simple method for the culture of microvascular endothelial cells from a small amount of tissue and investigated ulcerative colitis (UC), in which condition vascular factors have not been studied extensively. We cultured endothelial cells from the mesenteries of surgical patients with UC and assayed NOS activity by reduced nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase histochemistry. Strong NOS activity was demonstrated in the cells from all UC patients (5/5), whereas no activity was detected in the cells from human umbilical veins and the mesenteries of colon cancer patients (0/10 and 0/5, respectively). This strong NOS activity was not diminished by incubation with a high concentration of glucocorticoid, suggesting that it was constitutive. These results indicate a close relationship of vascular activation (high NOS activity) with the pathogenesis of UC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550872     DOI: 10.1007/bf02347578

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  16 in total

1.  High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.

Authors:  S H Murch; C P Braegger; W C Sessa; T T MacDonald
Journal:  Lancet       Date:  1992-02-15       Impact factor: 79.321

2.  Circulating von Willebrand factor in inflammatory bowel disease.

Authors:  T R Stevens; J P James; N J Simmonds; D A McCarthy; I F Laurenson; P J Maddison; D S Rampton
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

5.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

6.  Modulation of acute inflammation by endogenous nitric oxide.

Authors:  A Ialenti; A Ianaro; S Moncada; M Di Rosa
Journal:  Eur J Pharmacol       Date:  1992-02-11       Impact factor: 4.432

7.  Endogenous nitric oxide in gastric alkaline response in the rat stomach after damage.

Authors:  K Takeuchi; T Ohuchi; S Okabe
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

8.  Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  N K Boughton-Smith; S M Evans; C J Hawkey; A T Cole; M Balsitis; B J Whittle; S Moncada
Journal:  Lancet       Date:  1993-08-07       Impact factor: 79.321

9.  Increased nitric oxide synthesis in ulcerative colitis.

Authors:  S J Middleton; M Shorthouse; J O Hunter
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

10.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more
  5 in total

Review 1.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.

Authors:  F Obermeier; G Kojouharoff; W Hans; J Schölmerich; V Gross; W Falk
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice.

Authors:  K Yoshihara; T Yajima; C Kubo; Y Yoshikai
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

4.  Distribution of constitutive nitric oxide synthase in the jejunum of adult rat.

Authors:  Yan-Min Chen; Zhong-Ming Qian; Jian Zhang; Yan-Zhong Chang; Xiang-Lin Duan
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Regulation of Toll-like receptor 2 interaction with Ecgp96 controls Escherichia coli K1 invasion of brain endothelial cells.

Authors:  Subramanian Krishnan; Shuang Chen; Gianluca Turcatel; Moshe Arditi; Nemani V Prasadarao
Journal:  Cell Microbiol       Date:  2012-10-04       Impact factor: 3.715

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.